Lycke Kathrine D, Steben Marc, Garland Suzanne M, Woo Yin Ling, Cruickshank Margaret E, Perkins Rebecca B, Bhatla Neerja, Ryser Marc D, Gravitt Patti E, Hammer Anne
University Clinic for HPV-related gynecological disease, Department of Obstetrics and Gynecology, Gødstrup Hospital, Herning, Denmark; NIDO - Center for research and education, Gødstrup Hospital, Herning, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
School of Public Health, Université de Montréal, Montreal, QC, Canada.
Am J Obstet Gynecol. 2025 May;232(5):453-460. doi: 10.1016/j.ajog.2025.02.029. Epub 2025 Feb 19.
Recently, the International Papillomavirus Society convened a working group on cervical human papillomavirus latency, which resulted in an updated understanding of the human papillomavirus natural history. While the previous human papillomavirus natural history model considered human papillomavirus detection to be a result of human papillomavirus acquisition or possibly reinfection, and loss of human papillomavirus detection to be a result of viral clearance, the updated understanding of the human papillomavirus natural history is more nuanced. Thus, human papillomavirus detection may occur as a result of autoinoculation, deposition from a recent sex act, or as a redetection of a previously acquired infection. Similarly, loss of human papillomavirus detection likely reflects immune control rather than complete viral clearance. As it is practically impossible to identify the "true" source of a new human papillomavirus detection or determine why human papillomavirus is no longer detectable, we propose that healthcare providers and researchers use the terminology human papillomavirus detected vs human papillomavirus not detected. Moreover, we describe the updated understanding in a clinical context. Specifically, we discuss the potential implications of the updated understanding regarding clinical counseling in screening, recommendations on cervical screening, and human papillomavirus vaccination. We also suggest key phrases that healthcare providers may use when counseling women attending routine human papillomavirus-based cervical screening.
最近,国际乳头瘤病毒协会召集了一个关于宫颈人乳头瘤病毒潜伏的工作组,这使得对人乳头瘤病毒自然史有了更新的认识。虽然以前的人乳头瘤病毒自然史模型认为人乳头瘤病毒检测是感染人乳头瘤病毒或可能再次感染的结果,而人乳头瘤病毒检测结果转阴是病毒清除的结果,但对人乳头瘤病毒自然史的更新认识更为细致入微。因此,人乳头瘤病毒检测可能是自体接种、近期性行为传播或再次检测到先前感染的结果。同样,人乳头瘤病毒检测结果转阴可能反映的是免疫控制而非病毒完全清除。由于实际上不可能确定新检测到的人乳头瘤病毒的“真正”来源,也无法确定为何人乳头瘤病毒不再可检测到,我们建议医疗服务提供者和研究人员使用“检测到的人乳头瘤病毒”与“未检测到的人乳头瘤病毒”这一术语。此外,我们在临床背景下描述了这一更新的认识。具体而言,我们讨论了这一更新认识对筛查中的临床咨询、宫颈筛查建议以及人乳头瘤病毒疫苗接种的潜在影响。我们还建议了医疗服务提供者在为接受基于人乳头瘤病毒的常规宫颈筛查的女性提供咨询时可能使用的关键表述。